EXTREQOL Identifies Ongoing Challenges in Maximising Quality of Survival in Men with Metastatic Castrate-Resistant Prostate Cancer Jenkins V, Payne H, Mason M, May S, Matthew L, Catt S. Clinical Oncology. June 2018 Volume 30, Issue 6, Pages 331–333
Do drugs offering only PFS maintain quality of life sufficiently from a patient’s perspective? Results from AVALPROFS (Assessing the ‘VALue’ to patients of PROgression Free Survival) study. Jenkins V, Farewell V, May S, Catt S, Matthews L, Schilling V, Dickson J, Simcock R, Fallowfield L Supportive Care in Cancer. 15 May 2018
Enhancing decision-making about adjuvant chemotherapy in early breast cancer following EndoPredict testing.
Fallowfield L, Matthews L, May S, Bloomfield D Psycho-Oncology. April 2018 Volume 27, Issue 4, Pages: 1264-1269
Fallowfield L, Matthews L, Francis A, Jenkins V, Rea D. Low grade Ductal Carcinoma in situ (DCIS): How best to describe it?. The Breast, 23(5); 693-696
Francis A, Thomas J, Fallowfield L, Wallis M, Bartlett JMS, Brookes C, Roberts T, Pirrie S, Gaunt C, Young J, Billingham L, Dodwell D, Hanby A, Pinder SE, Evans A, Reed M, Jenkins V, Matthews L, Wilcox M, Fairbrother P, Bowden S, Rea D. Addressing overtreatment of screen detected DCIS; the LORIS trial. European Journal of Cancer, Article first published online 18th August 2015 ahead of print